Displaying 1041 - 1060 of 1575
Clinical Integration in Health Care: A Check-Up
FTCs Bureau of Competition Issues FY 2007 Summary of Pharmaceutical Company Settlement Agreements
North Texas Specialty Physicians
There is a related administrative proceeding.
On March 7, 2007, the Fifth Circuit Court of Appeals heard oral arguments in the appeal by respondents of the Commission's opinion in NTSP. The Court agreed with the Commission that the anticompetitive effects of NTSP’s practices were obvious. Per remand by the Court, the Commission modified one provision of its remedial order, issuing a Final Order in September 2008. On February 28, 2009, the U.S. Supreme Court denied NTSP's petition for review.
U.S. Court of Appeals Affirms FTC Decision That Texas Doctors Group Engaged in Illegal, Anticompetitive Price-Fixing
FTC and Virginia AG File Complaint in Federal Court Seeking to Block Inova Health System Foundations Acquisition of Prince William Health System
FTC Designates Commissioner J. Thomas Rosch as ALJ in Case Challenging Inova Health System Foundations Acquisition of Prince William Health System, Inc.
FTC and Virginia Attorney General Seek to Block Inova Health System Foundations Acquisition of Prince William Health System
Evanston Northwestern Healthcare Corporation and ENH Medical Group, Inc.
On February 10, 2004 the Commission issued an administrative complaint alleging that following Evanston Northwestern Healthcare Corporation's acquisition of Highland Park Hospital prices charged to health insurers for medical services increased and, therefore, higher costs for health insurance were passed on to consumers of hospital services in the Cook and Lake counties of Illinois. The complaint also alleged that a physicians group affiliated with both hospitals, Highland Park Independent Physician Group, negotiated prices for physicians on staff at Evanston as well as for several hundred independent physicians not affiliated with either hospital. According to the complaint, these actions constitute illegal price fixing among competing physicians or physician groups and deny consumers the benefits of competition in physician services. In an initial Decision, the Administrative law judge found that the acquisition resulted in higher prices and substantially lessened competition for acute care inpatient services in parts of Chicago’s northwestern suburbs. The ALJ entered an order that would require the divestiture of the acquired hospital. On appeal, the Commission ruled that the acquisition was anticompetitive, but concluded that in this “highly unusual case,” divestiture, the remedy imposed by the administrative law judge, would be too costly and potentially risky and instead imposed a conduct remedy. The Commission’s order requires Evanston to set up two separate and independent contract negotiation teams to bargain with managed care organizations to revive competition between Evanston’s two hospitals and the Highland Park hospital.
FTC Issues Final Opinion and Order to Restore the Competition Lost in Evanston Northwestern Healthcare Corporations Acquisition of Highland Park Hospital
Innovations in Health Care Delivery
FTC Submits Testimony to Florida State Senate Regarding Bill That Would Amend States Certificate of Need Laws
Commission Approves Final Consent Order in Matter of Connecticut Chiropractic Association
Connecticut Chiropractic Association, The; Connecticut Chiropractic Council, The; and Robert L. Hirtle, Esq., In the Matter of
The FTC challenged a group boycott between two Connecticut chiropractic associations in which the health care providers refused to deal with a cost-saving Connecticut health plan. The Commission issued a consent order ending the agreement and preventing the involved parties from entering into such agreements in the future.
Federal Trade Commission to Host Workshop on Health Care Clinical Integration
FTC to Host Workshop on Innovations in Health Care Delivery
FTC Challenges Illegal Boycott of Health Plan by Connecticut Chiropractors
Equitable Resources, Inc., Dominion Resources, Inc., Consolidated Natural Gas Company, and The Peoples Natural Gas Company
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order settling the charges required the sale of assets required to develop, manufacture, and market these vaccines to Wyeth. In addition, Schering-Plough was required to sign a supply and transition services agreement with Wyeth, under which Schering will provide the vaccines for a period of two years, allowing time for the necessary FDA approvals.
FTC Submits Testimony to Alaska House of Representatives Regarding Bill That Would Amend States Certificate of Need Laws
Displaying 1041 - 1060 of 1575